Benzinga's Weekend M&A Chatter - Baidu (NASDAQ:BIDU), Amgen (NASDAQ:AMGN)

The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday August 22 through Sunday August 25, 2013:

Amgen Near Deal to Acquire Onyx for $125/ShareThe Rumor

According to a report from the

New York Times

on Saturday, Amgen

AMGN

could announce a deal to acquire Onyx Pharmaceuticals

ONXX

as early as Monday, for $125 per share or $10.5 billion. On Wednesday

Reuters

reported that Onyx had agreed to allow Amgen and other potential bidders to view the company's Kryopolis trial data. Spokespersons for both companies have repeatedly declined comment on these reports. Onyx Pharmaceuticals closed at $116.94 Friday, a loss of $0.63.

Baidu Acquires 59% Interest in Renren's Nuomi for $160M in Cash

The Deal

Baidu

BIDU

and Renren

RENN

announced Friday that Baidu Holdings will acquire approximately 59% of the equity interest in Nuomi Holdings, a wholly-owned subsidiary of Renren, for $160 million in cash. The deal is expected to close in Q4 2013. Baidu closed at $138.64.86 Friday, a loss of $0.90, while Renren closed at $3.56, a gain of more than 4.5%.

BATS, Direct Edge Reportedly in Merger TalksThe Rumor

The BATS and Direct Edge exchanges are reportedly in merger talks, according to the

Wall Street Journal

. A combination of the rival exchanges would be larger than the Nasdaq OMX Group

NDAQ

, currently the second largest US exchange behind the NYSE Euronext

NYX

. Nasdaq OMX Group closed at $30.83 Friday, a gain of more than 1%, while NYSE Euronext closed at $42.66, losing $0.03.

Market News and Data brought to you by Benzinga APIs